Excelsior BioPharma Inc. (6496)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
23. 90
+0.3
+1.2712%
NT$
- Market Cap
- P/E Ratio
110% Div Yield
5,000 Volume
- Eps
NT$ 23.6
Previous Close Want to track 6496 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Excelsior BioPharma Inc. (6496) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.49B
Trailing P/E (ttm) -5.36
Forward P/E -
PEG ratio 0.13
Price/Sales (ttm) 1.18
Price/Book (mrq) 1.61
Enterprise Value/Revenue 1.59
Enterprise Value/EBITDA -11.62
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 58.3K
Average volume (90 days) 12.92K
Price summary
52-Week low 22.5
52-Week high 30.55
Beta -
50-Day moving average 24.26
200-Day moving average 24.76
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 28 Aug 2026
Ex-Dividend Date 28 May 2026
Last split factor 1:5
Last split Date 28 Nov 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.22%
Operating margin -0.21%
Operational effectiveness
Return on assets -0.15%
Return on equity -0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 20.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.43
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.03
Total debt (mrq) -
Total Debt/Equity (mrq) 0.76
Current ratio (mrq) 1.55%
Book value per share (mrq) 14.77
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
